September 1996

Maintenance Therapy for Chronic DepressionA Controlled Clinical Trial of Desipramine

Author Affiliations

University of Pittsburgh School of Medicine Western Psychiatric Institute and Clinic 3811 O'Hara St Pittsburgh, PA 15213

Arch Gen Psychiatry. 1996;53(9):775-776. doi:10.1001/archpsyc.1996.01830090019003

IN THIS ISSUE of the ARCHIVES, Kocsis et al1 present the results of their study on maintenance treatment for chronic depression. This study is an important sequel to their equally important earlier demonstration that patients with various forms of chronic depression do, indeed, respond to appropriate pharmacotherapy.2 With the publication of these results, we now also have evidence that the vast majority of responders to pharmacotherapy remain well when they receive the maintenance pharmacotherapy. These results nicely parallel the earlier findings of Prien et al3 and Frank et al4 with respect to maintenance treatment of recurrent depression.

In their present report on maintenance outcomes, Kocsis et al1 also discuss the "low" response rates to acute-phase pharmacotherapy in this population. There are several plausible explanations for the response rates obtained in the acute phase of their trial. First, Kocsis and colleagues chose the most stringent definition

First Page Preview View Large
First page PDF preview
First page PDF preview